Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 2/3 1Phase 1 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 3856Neoplasms 2988Prostatic Neoplasms 1751Colorectal Neoplasms 1426Lung Neoplasms 1327Motor Activity 802Head and Neck Neoplasms 683Pancreatic Neoplasms 662Colonic Neoplasms 655Uterine Cervical Neoplasms 648Carcinoma, Non-Small-Cell Lung 629Carcinoma, Hepatocellular 628Rectal Neoplasms 569Stomach Neoplasms 544Brain Neoplasms 483Ovarian Neoplasms 438Anxiety Disorders 419Pain 418Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 339Melanoma 322Multiple Myeloma 320Lymphoma 305Depression 305Endometrial Neoplasms 289Liver Neoplasms 279

Interventions

Sorafenib 1Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Interventional × HCC × Clear all
NCT06766773 2025-01-10

CWSRIH-HCC

The First People's Hospital of Neijiang

Phase NA Active not recruiting
80 enrolled

HCC

NCT01470495 2017-03-28

REPEAT

Southwest Hospital, China

Phase NA Unknown
430 enrolled

HCC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡